Skip to content

C.E Pharma

Active
Private limited companyfounded 2022active for 3 yearsRansfortstraat 87, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0793.409.817
Summary

The computed 12-month bankruptcy probability of C.E Pharma is 3.1% (moderate). The 2025 annual accounts show negative equity (-€46,167) and a net result of -€17,197. Equity is shrinking by about 69% per year across the filed financial years. Its solvency ranks better than 17% of 22,576 sector peers (NACE 47, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€263,031total assets 2025
Staff
1.1 FTE
Equity
-€46,167
Loss
-€17,197
Turnover not published (micro format)
Financial health
49 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
3.1%
Structure
2025 accounts filed 31 days late1 deed in the Belgian Official Gazette
Why 49raises riskLast filed accounts filed 31 days late; 3 of the last 3 lateSector: Retail trade (NACE 47)Founded in 2022lowers riskSize: total assets €263,031Show the evidence

Checked score

Score 2025
49 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 22% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 7-9
equity -17.6% of total assets
Liquidity 38-24
short-term debt 37.7% · cash 3.9%
Profitability 36+4
return on assets -6.5%
Bankruptcy probability, 12 months
3.1% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,242 companies, NACE 47, micro)
Last 24 months 11-2024: 5.1% 12-2024: 5.0%▼ -0.1 percentage points vs 11-2024 01-2025: 5.0%● unchanged vs 12-2024 02-2025: 5.0%● unchanged vs 01-2025 03-2025: 5.0%● unchanged vs 02-2025 04-2025: 4.9%▼ -0.1 percentage points vs 03-2025 05-2025: 5.0%▲ +0.1 percentage points vs 04-2025 06-2025: 4.9%▼ -0.1 percentage points vs 05-2025 07-2025: 4.7%▼ -0.2 percentage points vs 06-2025 08-2025: 5.4%▲ +0.7 percentage points vs 07-2025highest value 09-2025: 3.9%▼ -1.5 percentage points vs 08-2025 10-2025: 3.9%● unchanged vs 09-2025 11-2025: 3.9%● unchanged vs 10-2025 12-2025: 3.9%● unchanged vs 11-2025 01-2026: 3.9%● unchanged vs 12-2025 02-2026: 3.9%● unchanged vs 01-2026 03-2026: 3.9%● unchanged vs 02-2026 04-2026: 3.8%▼ -0.1 percentage points vs 03-2026 05-2026: 3.8%● unchanged vs 04-2026 06-2026: 3.8%● unchanged vs 05-2026 07-2026: 3.5%▼ -0.3 percentage points vs 06-2026 08-2026: 4.3%▲ +0.8 percentage points vs 07-2026 09-2026: 3.1%▼ -1.2 percentage points vs 08-2026 10-2026: 3.1%● unchanged vs 09-2026lowest value
No credit on open account
Liquidity insufficient (current ratio 0.96, compared with 0.97 in 2024, below 1; short-term debt: 37.7% and cash: 3.9% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 14% on solvency, 35% on liquidity, 27% on profitability and 10% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Last filed accounts filed 31 days late; 3 of the last 3 late
NBB · filings
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: total assets €263,031
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Founded in 2022
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
232425
2023 to 2025 · latest year -€46,167
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 3 filings
Deviation from the deadline
2025
31 days late
2024
31 days late
2023
68 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 43 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (3 of the last 3 filed years within 38 days of that day).
Companies Code · seven months
Where today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Weakest financial yearnet -€22,691

Financials · financial year 2025, micro format

2025 annual accounts filed late (31 days) Filed on 31 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00460503.

Equity
-€46,167▼ 59.4%
2024 · -€28,970
Total assets
€263,031▼ 21.8%
2024 · €336,365
Net result
-€17,197▲ 24.2%
2024 · -€22,691
Working capital
-€3,507▲ 23.0%
2024 · -€4,553
Trend over the years

2023 to 2025, 3 financial years

The operating result stays negative: a loss of €3,243 in 2025 against €12,708 in 2024; the loss shrinks.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€3,243 2025 Net result-€17,197 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result-€3,023--€12,708▼ 320%-€3,243▲ 74.5%
Net result-€16,279below the sector's middle half--€22,691below the sector's middle half▼ 39.4%-€17,197below the sector's middle half▲ 24.2%
Equity-€6,279below the sector's middle half--€28,970below the sector's middle half▼ 361%-€46,167below the sector's middle half▼ 59.4%
Total assets€349,028above the sector's middle half-€336,365above the sector's middle half▼ 3.6%€263,031within the sector's middle half▼ 21.8%
Debt€355,307-€365,335▲ 2.8%€309,199▼ 15.4%
Working capital-€1,147within the sector's middle half--€4,553within the sector's middle half▼ 297%-€3,507within the sector's middle half▲ 23.0%
Solvency-1.8%below the sector's middle half--8.6%below the sector's middle half▼ 6.8pp-17.6%below the sector's middle half▼ 8.9pp
Current ratio0.99within the sector's middle half-0.97within the sector's middle half▼ 0.020.96within the sector's middle half=
Return on assets (ROA)-4.7%below the sector's middle half--6.7%below the sector's middle half▼ 2.1pp-6.5%below the sector's middle half▲ 0.2pp
Staff (FTE)0.5-0.9▲ 80.0%1.1▲ 22.2%
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €263,031
Fixed assets €167,465 ▼ 17.9%
Current assets €95,566 ▼ 27.8%
Equity and liabilities
Equity-€46,167
Debt€309,199
Equity is negative: debt (€309,199) exceeds the balance-sheet total (€263,031).
Key figures and ratios
2025 value · change against 2024
EBITDA
€36,989▲
2024 · €26,194
Cash flow
€23,036▲
2024 · €16,211
Quick ratio
0.50▼
2024 · 0.68
Interest coverage
3.01▲
2024 · 2.62
Debt ≤ 1 year
€99,073▼
2024 · €136,961
Debt > 1 year
€210,125▼
2024 · €228,374
Income taxes
€1,942
Staff costs
€68,113▲
2024 · €49,481
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,555 companies that looked in July 2024 the way this one looks now, 4.6% went bankrupt within 24 months and 91.6% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a small loss
4.6% went bankrupt
3.6% stopped otherwise
91.6% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 3.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,555 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€336,365€263,031▼
Fixed assets21/28€203,957€167,465▼
Intangible fixed assets21€90,575€60,575▼
Tangible fixed assets22/27€113,271€106,779▼
Land and buildings22€94,029€91,198▼
Furniture and vehicles24€19,242€15,581▼
Financial fixed assets28€111€111=
Current assets29/58€132,408€95,566▼
Stocks and contracts in progress3€38,634€45,739▲
Stocks30/36€38,634€45,739▲
Amounts receivable within one year40/41€79,778€39,133▼
Trade receivables40€72,335€38,955▼
Other amounts receivable41€7,444€178▼
Current investments50/53€13,996-
Cash at bank and in hand54/58-€10,222
Deferred charges and accrued income490/1-€472
Equity and liabilities
Total equity and liabilities10/49€336,365€263,031▼
Equity10/15-€28,970-€46,167▼
Contributions10/11€10,000€10,000=
Profit (loss) carried forward14-€38,970-€56,167▼
Amounts payable17/49€365,335€309,199▼
Amounts payable after more than one year17€228,374€210,125▼
Financial debts170/4€228,374€210,125▼
Amounts payable within one year42/48€136,961€99,073▼
Current portion of amounts payable after more than one year42€18,419€19,503▲
Trade debts44€90,286€52,136▼
Suppliers440/4€90,286€52,136▼
Taxes, remuneration and social security45€5,971€14,556▲
Taxes450/3€2,593€3,790▲
Remuneration and social security454/9€3,378€10,766▲
Other amounts payable47/48€22,285€12,878▼
Income statement Code20242025
Remuneration, social security and pensions62€49,481€68,113▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€38,902€40,232▲
Other operating charges640/8€6,236€1,017▼
Gross operating margin9900€81,911€106,119▲
Operating profit (loss)9901-€12,708-€3,243▲
Financial income75/76B€23€268▲
Recurring financial income75€23€268▲
Financial charges65/66B€10,006€12,279▲
Recurring financial charges65€10,006€12,279▲
Profit (loss) for the period before taxes9903-€22,691-€15,254▲
Income taxes67/77-€1,942
Profit (loss) for the period9904-€22,691-€17,197▲
Profit (loss) for the period to be appropriated9905-€22,691-€17,197▲
Appropriation of the result
Profit (loss) to be appropriated9906-€38,970-€56,167▼
Profit (loss) brought forward from the previous period14P-€16,279-€38,970▼

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Remuneration, social security and pensions62€25,606€49,481€68,113▲ 37.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€58,012€38,902€40,232▲ 3.4%
Other operating charges640/8€1,048€6,236€1,017▼ 83.7%
Gross operating margin9900€81,643€81,911€106,119▲ 29.6%
Operating profit (loss)9901-€3,023-€12,708-€3,243▲ 74.5%
Financial income75/76B€7€23€268▲ 11×
Recurring financial income75€7€23€268▲ 11×
Financial charges65/66B€13,261€10,006€12,279▲ 22.7%
Recurring financial charges65€13,261€10,006€12,279▲ 22.7%
Profit (loss) for the period before taxes9903-€16,277-€22,691-€15,254▲ 32.8%
Income taxes67/77€2-€1,942-
Profit (loss) for the period9904-€16,279-€22,691-€17,197▲ 24.2%
Profit (loss) for the period to be appropriated9905-€16,279-€22,691-€17,197▲ 24.2%
Line202320242025Change
Assets
Total assets20/58€349,028€336,365€263,031▼ 21.8%
Fixed assets21/28€241,661€203,957€167,465▼ 17.9%
Intangible fixed assets21€120,575€90,575€60,575▼ 33.1%
Tangible fixed assets22/27€120,974€113,271€106,779▼ 5.7%
Land and buildings22€96,859€94,029€91,198▼ 3.0%
Furniture and vehicles24€24,115€19,242€15,581▼ 19.0%
Financial fixed assets28€111€111€111=
Current assets29/58€107,367€132,408€95,566▼ 27.8%
Stocks and contracts in progress3€33,292€38,634€45,739▲ 18.4%
Stocks30/36€33,292€38,634€45,739▲ 18.4%
Amounts receivable within one year40/41€23,725€79,778€39,133▼ 50.9%
Trade receivables40€23,725€72,335€38,955▼ 46.1%
Other amounts receivable41-€7,444€178▼ 97.6%
Current investments50/53€50,350€13,996--
Cash at bank and in hand54/58--€10,222-
Deferred charges and accrued income490/1--€472-
Equity and liabilities
Total equity and liabilities10/49€349,028€336,365€263,031▼ 21.8%
Equity10/15-€6,279-€28,970-€46,167▼ 59.4%
Contributions10/11€10,000€10,000€10,000=
Profit (loss) carried forward14-€16,279-€38,970-€56,167▼ 44.1%
Amounts payable17/49€355,307€365,335€309,199▼ 15.4%
Amounts payable after more than one year17€246,792€228,374€210,125▼ 8.0%
Financial debts170/4€246,792€228,374€210,125▼ 8.0%
Amounts payable within one year42/48€108,515€136,961€99,073▼ 27.7%
Current portion of amounts payable after more than one year42€19,442€18,419€19,503▲ 5.9%
Trade debts44€56,780€90,286€52,136▼ 42.3%
Suppliers440/4€56,780€90,286€52,136▼ 42.3%
Taxes, remuneration and social security45€3,517€5,971€14,556▲ 144%
Taxes450/3€3,517€2,593€3,790▲ 46.2%
Remuneration and social security454/9-€3,378€10,766▲ 219%
Other amounts payable47/48€28,776€22,285€12,878▼ 42.2%
Line202320242025Change
Profit (loss) for the period9904-€16,279-€22,691-€17,197▲ 24.2%
+ Depreciation and write-downs630€58,012€38,902€40,232▲ 3.4%
Operating cash flow (approximation)€41,733€16,211€23,036▲ 42.1%
Investment in fixed assets (approximation)--€1,198-€3,741▼ 212%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 31-08-2026 2026-00460503
31-12-2024 micro format 31-08-2025 2025-00454359
31-12-2023 micro format 07-10-2024 2024-00496658

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 5,204 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,892. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 8 November 2022, C.E Pharma was incorporated as a private limited company.1 Total assets went from €349,028 in 2023 to €263,031 in 2025 and headcount from 0.5 to 1.1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 31 days late
2025
31-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 31 days late
2024
31-12
Financial Weakest financial yearnet -€22,691
Net result drops to -€22,691, the lowest in the series; recovery starts the following year.
07-10
NBB filing Annual accounts filed
financial year 2023 · micro format · 68 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded08-11-2022
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0793409817
Also 9925:BE0793409817
Registered 03-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 26 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Sint-Jans-Molenbeek · 1 establishment unit since 2022
registered office establishment The establishment unit on the map
Ground area
89 m²
Building footprint
92 m²
Building volume
917 m³
Parcel 21523B0937/00G086, Brussels · tallest building 17.5 m. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
Ransfortstraat 87, 1080 Sint-Jans-Molenbeek
Retail sale of pharmaceutical products
since 2022unit no. 2.338.491.539
1 parcel
Brussels 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
21523B0937/00G086 Brussels 89 m² 1 · 92 m² 17.5 m · 4
How the parcels are linked
Good to know
The parcel matches the address exactly.